-
Want to enter the
Asian healthcare market?Let us open the door for you. -
Japan
A rapidly aging society.
A growing demand for healthcare.
We help you navigate the documentary and
regulatory complexities of Japan.$4175 126
-
Taiwan
A doorstep to the vast Chinese market.
We solidified our presence here in 2011
through a strategic acquisition.$1632 24
-
South Korea
Emerging as a top leader of clinical trials in Asia.
A CRO providing support for clinical trials and
application approval since 2007.$2150 52
-
Australia
A very friendly tax and regulatory environment.
We’ve had outstanding success with
clinical trials here since 2006.$5563 25
-
China
A country with a phenomenal growth rate.
Our expert multilingual staff has over
10 years experience here.$436 1398
-
Philippines
Tap into a huge ASEAN country.
Since 2004 we have been leveraging
this deep clinical resource pool.$124 108
-
Hong Kong
Offers efficient entry into the massive
Chinese market. With a base in Hong Kong
since 2008, we are situated to benefit
from evolving legislation.$2221 80/85
-
India
Home to 16% of the world's population,
20% of its disease. A growing biotech
market presents tremendous opportunity
for clinical trials.$65 1366
-
Malaysia
Multi-ethnic population and competitive
costs. Malaysia has an established healthcare
infrastructure that provides a solid foundation
for clinical research.$407 32
-
Singapore
A robust pharmaceutical and biotech center
for Asia. The country's high standards have
made Singapore an ideal headquarters for
EPSI's global arm since 2000.$2580 60
Share this page